Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples